#USA #New York #Securities Fraud #Rosen Law Firm #LifeMD

LifeMD Investors Face Class Action Opportunity

In recent news, the Rosen Law Firm, a premier global firm known for advocating investor rights, has alerted purchasers of LifeMD, Inc. securities about a crucial deadline. Between May 7, 2025, and August 5, 2025, those who acquired shares in this healthcare company may be eligible to participate in a securities fraud class action lawsuit.

Specifically, this announcement comes with the announcement of an upcoming lead plaintiff deadline set for October 27, 2025. Investors involved may have suffered losses due to what the firm claims were materially false or misleading statements made by the company's executives.

Why Join the Class Action?

The essence of joining this class action revolves around several key allegations against LifeMD's leadership. The defendants allegedly:
1. Exaggerated LifeMD's Competitive Standing: It’s claimed that LifeMD’s actual market position was notably misrepresented.
2. Neglected Rising Costs: There are allegations that the company hiked its 2025 financial expectations without fully factoring in surging customer acquisition costs tied to their RexMD segment and new drug sales like Wegovy and Zepbound.
3. Deceptive Communications: As a result, statements regarding LifeMD's operations and future prospects were claimed to be inherently misleading.

When these truths became public, investors reportedly experienced significant financial harm—a catalyst for the ongoing legal proceedings.

How to Engage

For investors wishing to be part of this class action, the Rosen Law Firm provides two straightforward avenues to proceed. Interested parties may either complete the online form available at Rosen Legal or make direct contact through the firm’s toll-free number at 866-767-3653. Additionally, inquiries can be submitted via email at [email protected].

It’s crucial to note that until a class is formally certified, investors seeking representation are not automatically represented unless they take proactive steps to retain counsel. Thus, retaining a qualified attorney can enhance your chance for recovery.

Why Choose Rosen Law Firm?

The Rosen Law Firm distinguishes itself through years of proven success in securities class action cases. Their expertise is not only recognized through numbers but also through important accolades. Ranked #1 by ISS Securities Class Action Services in 2017 for their number of settlements, the firm has, over years, secured hundreds of millions for investors. In 2019 alone, they recovered over $438 million. These significant achievements position them as a formidable ally in the legal landscape. Furthermore, the firm encourages investors to focus on choosing a law firm with the necessary experience and resources. Some firms merely function as intermediaries, lacking the pivotal experience needed for effective litigation.

Conclusion

For those impacted by uncertainties surrounding LifeMD, the class action lawsuit provides a powerful means of seeking restitution. This is an essential moment for investors who invested in LifeMD securities during the specified class period. Mark your calendars for October 27, 2025, lest you miss your opportunity to lead this action as a representative plaintiff. Participating in this case could potentially pave the way to recover against misleading corporate practices.

Follow updates from the Rosen Law Firm on social media platforms like LinkedIn, Twitter, or Facebook for ongoing information regarding this lawsuit and other legal matters pertinent to investors.